[email protected]/(408) 457-3700

About Core23 Biobank

A multi-million dollar opportunity exists to supply the medical community with a new and superior source of stem cells for transplantation in the treatment of cancer and many other serious diseases. The primary objective of Core23 Biobank is to meet this need through the collection, processing, and cryogenic storage of stem cells derived from the umbilical cord of a newborn baby following a live birth. Core23 Biobank offers expecting parents the opportunity to save their child’s umbilical cord blood, tissue and plasma at the time of birth and then have it processed and stored for later use in the event there is ever a need for it.

You need to register as an accredited investor before we can show you the details of any investment opportunities.

VentureHealth is currently invite only.

Request An Invite!

Startup's Info

Location:
Springfield
Markets:
Biotechnology